Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06505369
Title Bispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma Patients (TALTEC)
Acronym TALTEC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors North Estonia Medical Centre
Indications
Therapies
Age Groups: senior | adult
Covered Countries NOR | EST | DNK


No variant requirements are available.